Company profile: ReadCoor
1.1 - Company Overview
Company description
- Provider of the first true spatial multi-omic platform (RC2) that simultaneously detects and reads sequences, serving a global audience of researchers, clinicians, pharma and diagnostics companies to expand understanding of human biology and facilitate the creation of new therapeutics.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to ReadCoor
Decipher Bio
HQ: United States
Website
- Description: Provider of genomic tests for urological cancers, including Decipher Prostate for risk scores to guide treatment decisions and Decipher Bladder for molecular subtyping to aid planning, and the Decipher GRID research platform of whole-transcriptome profiles. Continues to build its GRID database and partners with pharmaceutical companies to identify biomarkers of response to novel therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Decipher Bio company profile →
TriLink BioTechnologies
HQ: United States
Website
- Description: Provider of custom oligonucleotides, modified nucleotides, long RNA and mRNA for the diagnostic, therapeutic and OEM markets, offering mRNA synthesis services and GMP mRNA manufacturing, CleanCap capping solutions, custom NTPs, specialty oligo synthesis, and in-house analytical method development and testing; also supplies CleanAmp PCR products and phosphoramidites.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full TriLink BioTechnologies company profile →
Biotheranostics
HQ: United States
Website
- Description: Provider of commercial-stage molecular diagnostics, delivering diagnostic, prognostic, and predictive tests that support physicians in treating cancer, including Breast Cancer Index, a genomic test predicting benefit of extended endocrine therapy in HR+, early-stage breast cancer, and CancerTYPE ID, a gene expression assay identifying tumor type/subtype in metastatic cancer with unknown or unclear diagnoses.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Biotheranostics company profile →
Razor Genomics
HQ: United States
Website
- Description: Provider of life science research and development focused on novel tests for the diagnosis of lung cancer, based in Brisbane.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Razor Genomics company profile →
ElevateBio
HQ: United States
Website
- Description: Provider of cell and gene-based therapy solutions, offering cGMP manufacturing and process development through BaseCamp; gene-editing capabilities with Life Edit; integrated technology platforms spanning gene editing, cell therapy enabling technologies, RNA engineering, and delivery; and development of in vivo and ex vivo therapeutic programs leveraging internal R&D and partnerships.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full ElevateBio company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for ReadCoor
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to ReadCoor
2.2 - Growth funds investing in similar companies to ReadCoor
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for ReadCoor
4.2 - Public trading comparable groups for ReadCoor
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →